✦ LIBER ✦

Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study

✍ Scribed by Jianghao Chen, Qing Yao, Dong Li, Juliang Zhang, Ting Wang, Ming Yu…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant bevacizumab, docetaxel and c

✍ R. Greil; M. Moik; R. Reitsamer; S. Ressler; M. Stoll; K. Namberger; C. Menzel; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 176 KB

4BA A randomized phase III study compari

✍ G.G. Steger; R. Greil; R. Jakesz; A. Lang; B. Mlineritsch; E. Melbinger-Zeinitze 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A phase II study of neoadjuvant chemothe

✍ Che Lin; Dar-Ren Chen; King-Jen Chang; Tsai-Wang Chang; Hwei-Chung Wang 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 252 KB

Safety and efficacy of toremifene in bre

✍ R. Valavaara; S. Pyrhönen; M. Heikkinen; P. Rissanen; G. Blanco; E. Nordman; P. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Neoadjuvant capecitabine (X), docetaxel

✍ W. Lybaert; Wildiers; P. Neven; P. Clement; M.R. Christiaens; C. Weltens; R. Dri 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 258 KB

A phase II study of epirubicin, cisplati

✍ Kenneth Villman; John F. Öhd; Elisabet Lidbrink; Lena Malmberg; Birgitta Lindh; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 339 KB